OC9.F Omnicell Inc

Healthcare Health Care Technology Frankfurt Exchange
31.00 EUR
Close of Nov 13, 2026
27.40 43.80
Market cap
EUR 1.43B
P/E
37.8x
P/B
1.24x
ROE
4.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is OC9.F undervalued?

Graham number
Price31.00
Graham value21.48
Premium44.3%

OC9.F trades 44.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Omnicell Inc fundamental analysis

No fundamental analysis for Omnicell Inc yet.

Omnicell Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automatio…

Full company profile